251
Views
18
CrossRef citations to date
0
Altmetric
Original research

Utilization of multiple spinal cord stimulation (SCS) waveforms in chronic pain patients

, , , &
Pages 663-668 | Received 19 Apr 2017, Accepted 20 Jun 2017, Published online: 12 Jul 2017
 

ABSTRACT

Background: Advances in spinal cord stimulation (SCS) have improved patient outcomes, leading to its increased utilization for chronic pain. Chronic pain is dynamic showing exacerbations, variable severity, and evolving pain patterns. Given this complexity, SCS systems that provide a broad range of stimulation waveforms may be valuable.

Methods: The aim of this research was to characterize the usage pattern of stimulation waveforms and field shapes in chronic pain patients implanted with the Spectra System. A review of daily device usage in a cohort of 250 patients implanted for a minimum duration of one month was conducted.

Results: With follow-ups ranging between 1 month and 1 year post-implant, 72.8% of patients used Standard Rate, 34.8% Anode Intensification, 23.2% Higher Rate, and 8.4% Burst stimulation waveforms. Collectively, 60% used 1 or more advanced waveforms, either exclusively or along with Standard Rate. A trend showed patients continuing to use up to 3 programs one year post-implant.

Conclusion: When given a choice, SCS patients often utilize a variety of waveforms, suggesting that patients may benefit from a single system that provides multiple waveforms and field shapes to customize therapy and improve efficacy.

Acknowledgment

The authors would like to thank Ramsey Samara of Boston Scientific Neuromodulation for assistance with manuscript writing and editing.

Declaration of interest

AP Berg has a consulting agreement with Boston Scientific Corporation. N Mekel-Bobrov is a previous employee of Boston Scientific Corporation. E Goldberg, D Huynh and R Jain are full-time, salaried employees of Boston Scientific Corporation. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

This paper has been funded by Boston Scientific Corporation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.